Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate

Clinical trial NCT00525213 · COMPLETED

Trial details

NCT number: NCT00525213
Sponsor: OxyPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2007-10-01
Primary completion: 2009-08-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.